# Oriel Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oriel-therapeutics

- Industry: Biotechnology
- Headquarters: Durham, US
- Website: www.orieltherapeutics.com
- Total disclosed funding: $23M
- Latest round: Series C (Nov 16, 2007)
- Investors on record: 3

## About

Oriel Therapeutics is a specialty pharmaceutical company engages in the development of dry powder delivery systems for the treatment of asthma and COPD.

## Funding rounds

- Series C, Nov 16, 2007, $23M — CHL Medical Partners, HealthCare Ventures, New Leaf Venture Partners

## Investors

- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series C
- HealthCare Ventures — Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series C